Journal article
Therapeutic Challenges in Combined Apical Ballooning Syndrome and Acute Pulmonary Decompensation
American journal of therapeutics, Vol.17(4), pp.E126-E130
07/01/2010
DOI: 10.1097/MJT.0b013e3181ba3320
PMID: 19829094
Abstract
Apical ballooning syndrome (ABS) is increasingly diagnosed in critical care settings. Widespread application of echocardiography and cardiac enzyme testing has increased its recognition. Our experience of 4 subjects illustrates the association of ABS with a wide spectrum of acute pulmonary disorders seen in critical care settings. All had ABS proven by normal coronary angiogram and subsequent normalization of left ventricular dysfunction. Bronchospasm due to chronic obstructive pulmonary disease exacerbation or cardiac failure warrants the use of beta agonists. ABS, on the other hand, being caused by excess sympathetic activity could potentially improve with beta blockade. Coexistence of ABS and pulmonary disease in critical-care settings presents unique therapeutic challenges and outcomes can be optimized by judicious use of available medical options.
Details
- Title: Subtitle
- Therapeutic Challenges in Combined Apical Ballooning Syndrome and Acute Pulmonary Decompensation
- Creators
- Chelif Junor - University of MissouriKimberly Delcour - University of MissouriAnand Chockalingam - University of Missouri
- Resource Type
- Journal article
- Publication Details
- American journal of therapeutics, Vol.17(4), pp.E126-E130
- Publisher
- Lippincott Williams & Wilkins
- DOI
- 10.1097/MJT.0b013e3181ba3320
- PMID
- 19829094
- ISSN
- 1075-2765
- eISSN
- 1536-3686
- Number of pages
- 5
- Language
- English
- Date published
- 07/01/2010
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984359882702771
Metrics
14 Record Views